Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
International Journal of Cancer|January 10, 2021
Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activationJia-Wern Pan, Muhammad Mamduh Ahmad Zabidi, Boon-Keat Chong, et al.The New England Journal of Medicine|March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancerSarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.The Lancet. Oncology|June 18, 2016
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysisTarek M A Abdel-Fatah, Devika Agarwal, Dong-Xu Liu, et al.Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.Communications Biology|April 4, 2020
DNA copy number motifs are strong and independent predictors of survival in breast cancerArne V Pladsen, Gro Nilsen, Oscar M Rueda, et al.Nature Communications|December 23, 2016
p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesisRobert A H van de Ven, Jolien S de Groot, Danielle Park, et al.Nature Communications|July 16, 2019
Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesisRobert A H van de Ven, Jolien S de Groot, Danielle Park, et al.Nature Communications|January 10, 2015
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cellsWalid T Khaled, Song Choon Lee, John Stingl, et al.Breast Cancer Research : BCR|April 22, 2024
Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypesJia-Wern Pan, Mohana Ragu, Wei-Qin Chan, et al.EMBO Molecular Medicine|June 1, 2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerDana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, et al.Pageof 10